Piezoelectric nanozymes offer a versatile platform for multimodal cancer therapy and represent a promising paradigm for developing strategies for precise, non-invasive cancer therapy through localized ROS generation and modulation of the TME.
Abstract
Cancer remains a critical global health challenge, leading to millions of deaths worldwide due to its rapid progression and complex resistance mechanisms. However, conventional therapeutic modalities are frequently constrained by tumor hypoxia, heterogeneity, therapeutic resistance, and off-target toxicity, emphasizing the necessity for robust and precise therapeutic approaches. Development of nanozyme-based approaches has provided innovative avenues for catalytic cancer therapy. However, the therapeutic capability of traditional approaches is often hindered by low catalytic efficiency and minimal production of reactive oxygen species (ROS) within the tumor microenvironment (TME). Consequently, piezoelectric nanozymes have emerged as a next-generation category of multifunctional nanocatalysts that integrate enzyme-mimicking catalytic activity with piezoelectric energy conversion, enabling effective and accurate tumor treatment under external mechanical stimulation. Piezoelectric polarization-mediated enhanced charge separation facilitates catalytic amplification, ROS generation, enhanced electron (e
−
) transfer, and redox regulation, thereby addressing major constraints associated with conventional therapeutic techniques. This review comprehensively describes the charge-generating properties of piezoelectric materials with enzyme-mimicking catalytic activity, catalytic mechanisms, design strategies and current advancements in piezoelectric nanozyme-driven cancer therapy. Sonodynamic therapy (SDT), ferroptosis therapy, radiocatalytic therapy(RCT), starvation therapy (ST), piezocatalytic therapy(PCT), chemodynamic therapy (CDT), immunotherapy, and their synergistic combinations are all discussed in detail. Piezoelectric nanozymes offer a versatile platform for multimodal cancer therapy and represent a promising paradigm for developing strategies for precise, non-invasive cancer therapy through localized ROS generation and modulation of the TME.
This review systematically summarizes recent advances in nanozyme-mediated regulation of the TME and aims to provide a theoretical basis and research perspectives for the further study, rational design, and translational application of nanozymes in cancer therapy.
Xin-Yang Zhang, Zi-Qi Wang, Yang Niu et al.· Biomaterials Research· 0 citations
Reactive oxygen species (ROS)-mediated cancer therapy has emerged as a promising strategy for inducing oxidative stress and cancer cell death. Among available nanomaterials, magnetic nanoparticles (MNPs) are particularly attractive because of their magnetic responsiveness, tunable physicochemical properties, and capaci...
G. Kurmanalina, V. Medovchshikov, Setareh Valanik et al.· Frontiers in Oncology· 0 citations
Nanozyme-based catalytic therapy triggered by tumor-specific endogenous stimuli is an emerging tumor therapy that has attracted significant attention. Nevertheless, the efficacy of current catalytic therapies is severely limited by the intrinsic catalytic efficiency of nanozymes and the low concentration of endogenou...
Lu Zhao, Liang Zhu, Chao-Yu Wang et al.· ACS Omega· 0 citations
Tumor catalytic therapy (TCT), an emerging therapeutic modality, exerts specific cytotoxic effects on tumor cells by catalyzing endogenous substances within the tumor microenvironment (TME)—including hydrogen peroxide (H
2
O
2
), glucose, and glutathione—to generate reactive oxygen species (ROS) or deplete prot...
You-Yu Wang, Shu-Wei Zhang, Yang-Ke He et al.· Rare Metals· 0 citations
Cancer remains one of the leading causes of mortality worldwide, necessitating the development of more precise and effective therapeutic strategies. Graphitic carbon nitride (g-C₃N₄) has emerged as a highly promising metal-free semiconductor nanomaterial for photocatalytic cancer therapy owing to its tunable bandgap (~...
A "trinity" synergistic design paradigm is proposed, which exploits pathological mitochondrial signals as dual-functional cues for both subcellular navigation and catalytic activation, thereby achieving temporal coupling of "targeting enrichment" and "responsive activation."
Yong-Xiang Wei, Zi-Yi Yuan, Yuan-Ke Zhang et al.· Small Methods· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.